20.6 C
New York
Thursday, June 18, 2026

Tag: Johnson

newssourceFORcompanyinformationcontent1marketreleases

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation MARLBOROUGH, Mass., July 7, 2025 /PRNewswire/...

QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

New executives bring deep expertise to elevate quality and accelerate innovation across global operations SAN DIEGO, July 7, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the...

AI Buddy: Friend or Fad?

What can a purple alien teach us about human relationships? Turns out, more than your average AI chatbot. The alien in question is a...

Strüngmann Award zeichnet Gründerteam von Araris Biotech als Preisträger 2025 aus

München, Deutschland, 04. Juli 2025 – Das Komitee des Strüngmann Award gab heute bekannt, dass Dr. Dragan Grabulovski, Dr. Philipp Spycher und Dr. Isabella Attinger-Toller, die Gründer von Araris Biotech, als die diesjährigen Preisträger ausgezeichnet wurden. Der Award verfolgt das Ziel, herausragende unternehmerische und wissenschaftliche Leistungen sowie bahnbrechende Ideen in der Life-Science-Branche zu fördern. Das Gründerteam von Araris Biotech überzeugte nicht nur durch die Entwicklung einer neuartigen Technologie im Bereich der Antikörper-Wirkstoff-Konjugate, sondern auch durch deren erfolgreiche Validierung in Form von Partnerschaften und einem präklinischen Exit. Diese neue Medikamentenklasse hat das Potenzial, maßgeblich zur Weiterentwicklung zielgerichteter Krebstherapien beizutragen und somit einen Mehrwert für Menschen mit Krebserkrankungen weltweit zu erreichen. 

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

Munich, Germany, July 04, 2025 – The Strüngmann Award selection committee today announced that Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D., the founders of Araris Biotech, have been honored as this year’s winners. The award aims to support outstanding entrepreneurial and scientific achievements, as well as ground-breaking ideas in the life sciences industry. Araris Biotech’s founding team distinguished itself not only by developing of a novel technology in the antibody-drug conjugates (ADCs) field, but also by successfully validating this innovation through partnerships and a preclinical exit. This new drug class has the potential to significantly advance the development of targeted cancer therapies, thereby delivering added value for people living with cancer worldwide.

Johnson Fistel, PLLP Investigates Telephone and Data Systems, Fluence Energy, The Bancorp, and Zynex on Behalf of Long-Term Shareholders

SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating potential violations of federal and state securities laws by certain officers and directors of the following companies: Telephone and Data Systems, Inc. (NYSE: TDS), Fluence Energy, Inc. (NASDAQ: FLNC), The Bancorp, Inc. (NASDAQ: TBBK), Zynex, Inc. (NASDAQ: ZYXI). Long-term shareholders of any of these companies who have continuously held shares during the relevant time periods may be able to hold certain officers and directors personally accountable for misconduct and assist in reforming the company’s corporate governance.

Johnson Fistel Continues Investigation on Behalf of Proficient Auto Logistics, Inc. (PAL) Shareholders

SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Proficient Auto Logistics, Inc. (NASDAQ: PAL) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material information to investors. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.

Shareholder Alert: Johnson Fistel, LLP Investigates Elanco Animal Health, Masimo, Fidelity National Information, and Super Micro Computer —Long-Term Investors are Encouraged to Contact the...

SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, is investigating potential violations of federal and state laws by officers and directors of Elanco Animal Health Incorporated (NYSE: ELAN), Masimo Corporation (NASDAQ: MASI), Fidelity National Information Services, Inc. (NYSE: FIS), and Super Micro Computer, Inc. (NASDAQ: SMCI).

Investigation Alert: The Estée Lauder Companies, Driven Brands Holdings, Hasbro, and TransMedics: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors

SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) --

Johnson Fistel, PLLP is investigating potential violations of federal and state laws by certain officers of the following companies: The Estée Lauder Companies Inc. (NYSE: EL), Driven Brands Holdings Inc. (NASDAQ: DRVN), Hasbro, Inc. (NASDAQ: HAS), and TransMedics Group, Inc. (NASDAQ: TMDX).

Investor Alert: Johnson Fistel Investigates Methode Electronics, Integral Ad Science, Manhattan Associates, and Crocs on Behalf of Shareholders

SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential violations of federal and state securities laws by certain officers and directors of the following companies: Methode Electronics, Inc. (NYSE: MEI), Integral Ad Science Holding Corp. (NASDAQ: IAS), Manhattan Associates, Inc. (NASDAQ: MANH), and Crocs, Inc. (NASDAQ: CROX).

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team

Renewable energy market set for major boost as SKF announces tidal stream breakthrough

GOTHENBURG, Sweden, July 3, 2025 /PRNewswire/ -- SKF has joined forces with Proteus Marine Renewables to deliver cutting-edge technology for MeyGen. Operated by SAE Renewables,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsJohnson

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers